Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Return on Capital Employed (2016 - 2026)

Ekso Bionics Holdings has reported Return on Capital Employed over the past 12 years, most recently at 1.09% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 57.0% to 1.09% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.09%, a 57.0% decrease, with the full-year FY2025 number at 0.9%, down 39.0% from a year prior.
  • Return on Capital Employed reached 1.09% in Q4 2025 per EKSO's latest filing, down from 0.82% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.24% in Q2 2021, with the low at 1.09% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 0.55% (2023), against an average of 0.55%.
  • Peak YoY movement for Return on Capital Employed: soared 103bps in 2021, then tumbled -57bps in 2025.
  • Tracing EKSO's Return on Capital Employed over 5 years: stood at 0.32% in 2021, then plummeted by -57bps to 0.5% in 2022, then plummeted by -37bps to 0.69% in 2023, then grew by 26bps to 0.51% in 2024, then tumbled by -112bps to 1.09% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 1.09%, 0.82%, and 0.66% for Q4 2025, Q3 2025, and Q2 2025 respectively.